KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Operating Expenses (2017 - 2025)

Twist Bioscience (TWST) has disclosed Operating Expenses for 6 consecutive years, with $117.1 million as the latest value for Q3 2023.

  • On a quarterly basis, Operating Expenses rose 2.52% to $117.1 million in Q3 2023 year-over-year; TTM through Sep 2023 was $462.3 million, a 5.46% increase, with the full-year FY2025 number at $512.8 million, down 3.93% from a year prior.
  • Operating Expenses was $117.1 million for Q3 2023 at Twist Bioscience, down from $124.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $124.5 million in Q2 2023 to a low of $39.8 million in Q1 2019.
  • A 5-year average of $81.3 million and a median of $77.1 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: surged 679.97% in 2019, then decreased 16.49% in 2020.
  • Twist Bioscience's Operating Expenses stood at $73.0 million in 2019, then decreased by 16.49% to $61.0 million in 2020, then skyrocketed by 60.71% to $98.0 million in 2021, then increased by 0.93% to $98.9 million in 2022, then increased by 18.39% to $117.1 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Operating Expenses are $117.1 million (Q3 2023), $124.5 million (Q2 2023), and $121.8 million (Q1 2023).